Background. Meningitis with a negative CSF Gram stain represents a diagnostic and therapeutic challenge, as the majority of the causative organisms are unknown. Novel and fast molecular techniques may increase the detection of the etiological agents.
Methods. Patients admitted to 4 hospitals in Houston, TX between November 2008 -March 2014 with community-acquired meningitis (fever, headache, vomiting, photophobia, stiff neck, focal neurological symptoms), CSF cell count > 5 cells/mm 3 and a negative CSF Gram stain were eligible. Residual patient CSF underwent additional testing by a research use only version of the FilmArray™ Meningitis/Encephalitis panel (FA ME, BioFire Diagnostics, LLC). The panel requires 200 µL CSF and simultaneously tests for 6 bacteria (S. pneumoniae, N. meningitidis, S. agalactiae, H. influenzae, L. monocytogenes, E. coli K1), 8 viruses (Herpes simplex types 1, 2, 6, Cytomegalovirus, Epstein-Barr virus [EBV], Enterovirus, Parechovirus, Varicella zoster virus [VZV] ) and 2 fungi (Cryptococcus neoformans and gattii).
Results. Of the 149 patients enrolled, 48 (32.2%) had residual CSF (38 adults, 10 children < age 18) available for FA ME testing. Pathogens were identified in 14 (29.2%) of 48 samples by standard evaluation and 15 (31.2%) by FA ME. Among FA ME results, viral pathogens were most common [EBV (8), HSV2 (3), VZV (3), HSV1 (1), enterovirus (1)], followed by bacterial [S. pneumoniae (2)] and fungal [C. neoformans (1)]. Co-detections were present in 6 patients (12.5%); EBV was present in all (6) along with VZV (2), HSV1 (1), HSV2 (1), C. neoformans (1), and S. pneumoniae (1). In 8 (16.6%) patients, FA ME identified pathogens not previously identified. Standard evaluations identified pathogens in 5 (15.2%) of 33 FA ME negative samples [West Nile Virus (WNV) (4), Histoplasma capsulatum (1)].
Conclusion. Testing with the FA ME panel resulted in pathogen detections not previously recognized and for which treatment is recommended. The FA ME panel did not, however, detect some pathogens identified by standard techniques; assays for WNV and Histoplasma are not contained on the panel. Rapid, comprehensive testing for the most common pathogens causing meningitis will aid in the diagnosis and treatment of patients with meningitis.
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